| Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ... Nature Communications 10 (1), 213, 2019 | 125* | 2019 |
| Nuclear phosphoinositides: their regulation and roles in nuclear functions R Fiume, I Faenza, B Sheth, A Poli, MC Vidalle, C Mazzetti, SH Abdul, ... International Journal of Molecular Sciences 20 (12), 2991, 2019 | 57 | 2019 |
| Functional dissection of inherited non-coding variation influencing multiple myeloma risk R Ajore, A Niroula, M Pertesi, C Cafaro, M Thodberg, M Went, EL Bao, ... Nature communications 13 (1), 151, 2022 | 25 | 2022 |
| Genetic predisposition to multiple myeloma at 5q15 is mediated by an ELL2 enhancer polymorphism N Li, DC Johnson, N Weinhold, S Kimber, SE Dobbins, JS Mitchell, ... Cell reports 20 (11), 2556-2564, 2017 | 25 | 2017 |
| An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics PH Hoang, AJ Cornish, AL Sherborne, D Chubb, S Kimber, G Jackson, ... Blood Cancer Journal 10 (10), 101, 2020 | 13 | 2020 |
| Modulating phosphoinositide profiles as a roadmap for treatment in acute myeloid leukemia S Ratti, C Evangelisti, S Mongiorgi, A De Stefano, A Fazio, F Bonomini, ... Frontiers in Oncology 11, 678824, 2021 | 6 | 2021 |
| A mutant of uracil DNA glycosylase that distinguishes between cytosine and 5-methylcytosine ST Kimber, T Brown, KR Fox PloS one 9 (4), e95394, 2014 | 6 | 2014 |
| Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells A Poli, R Fiume, S Mongiorgi, A Zaurito, B Sheth, MC Vidalle, SA Hamid, ... Advances in Biological Regulation 76, 100722, 2020 | 5 | 2020 |
| Cytosine variant detection KR Fox, T Brown, ST Kimber US Patent App. 14/325,067, 2015 | 5 | 2015 |
| Identifying ultra-high risk myeloma by integrated molecular genetic and gene expression profiling AL Sherborne, A Price, DC Johnson, S Ellis, C Smith, F Mirabella, ... Blood 128 (22), 4407, 2016 | 4 | 2016 |
| DNA Methylation Profiling of Myeloma Trial Patients Reveals Specific Epigenetic Changes Associated with Outcome DC Johnson, DB Begum, S Ellis, AL Sherborne, A Price, C Smith, ... Blood, The Journal of the American Society of Hematology 128 (22), 804-804, 2016 | 1 | 2016 |
| The effect of sequence context on the activity of cytosine DNA glycosylases ST Kimber, T Brown, KR Fox Molecular BioSystems 11 (12), 3273-3278, 2015 | 1 | 2015 |
| Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (vol 9, 3707, 2018) M Went, A Sud, A Foersti, BM Halvarsson, N Weinhold, S Kimber, ... Nature Communications 10 (1), 2019 | | 2019 |
| Integrating Molecular Genetic and Gene Expression Profiling Allows Stratification of Ultra-High Risk Myeloma A Sherborne, A Price, D Johnson, S Ellis, C Smith, F Mirabella, ... Clinical Lymphoma, Myeloma and Leukemia 17 (1), e1-e2, 2017 | | 2017 |
| Utilising Uracil DNA Glycosylase to detect the presence of 5-Methylcytosine ST Kimber University of Southampton, 2014 | | 2014 |
Martin KaiserProfessor of Haematology, Institute of Cancer Research LondonVerified email at icr.ac.uk
